TCBP (TC BioPharm (Holdings) Plc) Net Profit
TC Biopharm leverages exclusive T-cell modification patents to maintain leadership in oncology. The company's profit margins reflect current trends, with the indicator holding at 0.00. This is driven by intensive development of affordable allogeneic treatments for blood cancer. Simultaneously, the business is implementing ESG standards, ensuring ethical bio-waste disposal and strict compliance during clinical trials.
%20Plc%20Net%20Income&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_TCBP_-_TC-Biopharm_-_Net-Income "TCBP: TC BioPharm (Holdings) Plc Final Profit 04/28/2023 - 03/29/2025 | 👁️GURU.Markets👁️")
Analytical breakdowns and data insights for company TC BioPharm (TCBP)
- price and consensus price forecast:
- business market valuation indicators:
- book capitalization data:
- debt and solvency information:
Total Debt to Equity Ratio TC Biopharm|TCBP - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio TC BioPharm (Holdings) Plc|TCBP - Company Total Debt|Debts to Book Capitalization TC Biopharm|TCBP - Company Long-Term Debt|Company Short-Term Indebtedness TC BioPharm|Immediate Liquidity tcbiopharm.com
- net income and valuation multiples indicators:
Summary company analysis:TC Biopharm
Investors are assessing business resilience through net income dynamics, which capture the real efficiency of the operating model without market distortions. The current value of 0.00 reflects the final financial result after deducting all expenses, which is critical for the cell therapy developer TC Biopharm (TCBP) during the transition from the R&D stage to the commercialization of immunotherapeutic drugs, determining the company's profit margin.
Main competitors
Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|PGEN: Net Income|Pharming Corp - Profit After Payment of Taxes|NKTR: Net Profit|Net Income upstreambio.com|Net Income ZBIO|IMNM: Final Profit|Net Profit GOSS|Company Net Income KALV (KalVista Corp)|Net Profit SEPN (Septerna Inc)|Net Financial Result pieris.com (PVLA)|SVRA - Company Net Income|Company Net Income Rigel Pharma|AnaptysBio Corp (ANAB) - Company Net Income|Profit After Tax ATXS (Astria Corp)|ENGN (enGene Holdings Inc.) - Net Profit|RAPT: Final Profit|Net Profit JBIO|Net Profit Aclaris Therapeutics Inc. (ACRS)|Company Net Income Kyverna KYTX|Final Profit TLSA|CABA - Company Net Income|ventyxbio.com (VTYX) - Net Income|THTX (Theratechnologies) - Net Income|AVTX: Profit After Payment of Taxes|ELDN (Eledon) - Net Profit|Net Income Agenus, Inc (AGEN)|Net Profit CLYM|Company Net Income ZURA (zurabio.com)|Company Net Income aTyr Pharma ATYR|ADAG (Adagene Inc) - Profit After Tax|IMA - Company Net Income|Profit After Tax STTK|EQ: Net Profit|Connect Biopharma Holdings Limited - Final Profit|IMUX (Immunic Therapeutics) - Net Profit|Net Profit Atara Biotherapeutics Inc|Company Net Income InflaRx N.V. (IFRX)|XFOR (X4 Pharmaceuticals, Inc) - Final Profit|Company Net Income Adicet Bio, Inc. ACET|CELU - Net Income|INmune Bio - Net Profit|BRNS - Net Profit|KZR (Kezar Life Sciences, Inc) - Net Income|SAB Biotherapeutics Inc - Final Profit|AKTX (Akari Therapeutics) - Net Profit|Enlivex Therapeutics, Ltd. (ENLV) - Net Financial Result|Company Net Income Q32 Bio Inc. (QTTB)|Net Income GeoVax Labs GOVX|Company Net Income Edesa EDSA|IBIO - Net Income|CARM: Net Income|XTLB - Net Profit|boltbio.com (BOLT) - Company Net Income|Company Profit HCWB|APVO (Aptevo Therapeutics, Inc.) - Net Profit|Company Net Income aimimmuno.com AIM|Net Income ADTX (Aditxt)|Profit After Payment of Taxes GRI|Net Profit XRTX (XORTX Therapeutics)|HIND - Net Income|REVB: Net Income|Final Profit INDP (Indaptus Corp)|SCNI: Net Profit|CALI (CalciMedica) - Company Net Income|AFMD (Affimed NV) - Net Profit|Allakos Therapeutics (ALLK) - Net Financial Result|Company Net Income HOOKIPA Pharma Inc. (HOOK)|IGMS - Company Net Income|Company Net Income iTeos Therapeutics ITOS|OCEA (oceanbiomedical.com) - Profit After Tax|Third Harmonic Bio, Inc. - Net Profit